The Secretome of Endothelial Progenitor Cells: a Potential Therapeutic Strategy for Ischemic Stroke

Overview

Journal Neural Regen Res

Date 2021 Jan 12

PMID 33433461

Citations 20

Authors

Mansour Alwjwaj

Rais Reskiawan A Kadir

Ulvi Bayraktutan

Affiliations

Soon will be listed here.

Abstract

Ischemic stroke continues to be a leading cause of mortality and morbidity in the world. Despite recent advances in the field of stroke medicine, thrombolysis with recombinant tissue plasminogen activator remains as the only pharmacological therapy for stroke patients. However, due to short therapeutic window (4.5 hours of stroke onset) and increased risk of hemorrhage beyond this point, each year globally less than 1% of stroke patients receive this therapy which necessitate the discovery of safe and efficacious therapeutics that can be used beyond the acute phase of stroke. Accumulating evidence indicates that endothelial progenitor cells (EPCs), equipped with an inherent capacity to migrate, proliferate and differentiate, may be one such therapeutics. However, the limited availability of EPCs in peripheral blood and early senescence of few isolated cells in culture conditions adversely affect their application as effective therapeutics. Given that much of the EPC-mediated reparative effects on neurovasculature is realized by a wide range of biologically active substances released by these cells, it is possible that EPC-secretome may serve as an important therapeutic after an ischemic stroke. In light of this assumption, this review paper firstly discusses the main constituents of EPC-secretome that may exert the beneficial effects of EPCs on neurovasculature, and then reviews the currently scant literature that focuses on its therapeutic capacity.

Citing Articles

Secretome from hypoxic mesenchymal stem cells as a potential therapy for ischemic stroke: Investigations on and expression.

Silvana S, Japardi I, Rusda M, Daulay R, Putra A, Mangunatmadja I Narra J. 2025; 4(3):e1181.

PMID: 39816066 PMC: 11732002. DOI: 10.52225/narra.v4i2.1181.

Efficacy and safety of very early rehabilitation for acute ischemic stroke: a systematic review and meta-analysis.

Lou Y, Liu Z, Ji Y, Cheng J, Zhao C, Li L Front Neurol. 2024; 15:1423517.

PMID: 39502386 PMC: 11534803. DOI: 10.3389/fneur.2024.1423517.

Anti-inflammatory Prowess of endothelial progenitor cells in the realm of biology and medicine.

Hassanpour M, Salybkov A, Kobayashi S, Asahara T NPJ Regen Med. 2024; 9(1):27.

PMID: 39349482 PMC: 11442670. DOI: 10.1038/s41536-024-00365-z.

Comparative transcriptomic analysis of circulating endothelial cells in sickle cell stroke.

de Castro J, da Silva Costa S, Camargo A, Ito M, de Souza B, Bertozzo V Ann Hematol. 2024; 103(4):1167-1179.

PMID: 38386032 DOI: 10.1007/s00277-024-05655-6.

Secretome of bovine umbilical vein endothelial cells promote wound healing regeneration on the second degree rat model burn injury.

Moghan M, Naidu P, Zulkifly N, Selan Y, Setyawan E, Winarsih S Open Vet J. 2024; 13(12):1597-1606.

PMID: 38292702 PMC: 10824095. DOI: 10.5455/OVJ.2023.v13.i12.9.

References

Levy M, Crawford J, Dib N, Verkh L, Tankovich N, Cramer S . Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke. Stroke. 2019; 50(10):2835-2841. DOI: 10.1161/STROKEAHA.119.026318. View

Hur J, Yoon C, Kim H, Choi J, Kang H, Hwang K . Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2003; 24(2):288-93. DOI: 10.1161/01.ATV.0000114236.77009.06. View

Condon E, Wang J, Redmond H . Surgical injury induces the mobilization of endothelial progenitor cells. Surgery. 2004; 135(6):657-61. DOI: 10.1016/j.surg.2003.10.012. View

Rehman J, Li J, Orschell C, March K . Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003; 107(8):1164-9. DOI: 10.1161/01.cir.0000058702.69484.a0. View

Fann D, Lee S, Manzanero S, Chunduri P, Sobey C, Arumugam T . Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res Rev. 2013; 12(4):941-66. DOI: 10.1016/j.arr.2013.09.004. View

Urbich C, De Souza A, Rossig L, Yin X, Xing Q, Prokopi M . Proteomic characterization of human early pro-angiogenic cells. J Mol Cell Cardiol. 2010; 50(2):333-6. DOI: 10.1016/j.yjmcc.2010.11.022. View

Medina R, ONeill C, ODoherty T, Chambers S, Guduric-Fuchs J, Neisen J . Ex vivo expansion of human outgrowth endothelial cells leads to IL-8-mediated replicative senescence and impaired vasoreparative function. Stem Cells. 2013; 31(8):1657-68. DOI: 10.1002/stem.1414. View

Abdullah Z, Bayraktutan U . Suppression of PKC-α attenuates TNF-α-evoked cerebral barrier breakdown via regulations of MMP-2 and plasminogen-plasmin system. Biochim Biophys Acta. 2016; 1862(7):1354-66. DOI: 10.1016/j.bbadis.2016.03.014. View

Wolburg H, Lippoldt A . Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2003; 38(6):323-37. DOI: 10.1016/s1537-1891(02)00200-8. View

10.

Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M . Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999; 5(4):434-8. DOI: 10.1038/7434. View

11.

Reis C, Wilkinson M, Reis H, Akyol O, Gospodarev V, Araujo C . A Look into Stem Cell Therapy: Exploring the Options for Treatment of Ischemic Stroke. Stem Cells Int. 2017; 2017:3267352. PMC: 5671750. DOI: 10.1155/2017/3267352. View

12.

Lipton S, Rosenberg P . Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994; 330(9):613-22. DOI: 10.1056/NEJM199403033300907. View

13.

Carvey P, Hendey B, Monahan A . The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J Neurochem. 2009; 111(2):291-314. PMC: 2761151. DOI: 10.1111/j.1471-4159.2009.06319.x. View

14.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

15.

Gallina C, Turinetto V, Giachino C . A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome. Stem Cells Int. 2015; 2015:765846. PMC: 4436518. DOI: 10.1155/2015/765846. View

16.

Tajiri N, Acosta S, Glover L, Bickford P, Simancas A, Yasuhara T . Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One. 2012; 7(8):e43779. PMC: 3422299. DOI: 10.1371/journal.pone.0043779. View

17.

Medina R, ONeill C, Sweeney M, Guduric-Fuchs J, Gardiner T, Simpson D . Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics. 2010; 3:18. PMC: 2881111. DOI: 10.1186/1755-8794-3-18. View

18.

Lodi D, Iannitti T, Palmieri B . Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res. 2011; 30:9. PMC: 3033847. DOI: 10.1186/1756-9966-30-9. View

19.

Hayakawa K, Chan S, Mandeville E, Park J, Bruzzese M, Montaner J . Protective Effects of Endothelial Progenitor Cell-Derived Extracellular Mitochondria in Brain Endothelium. Stem Cells. 2018; 36(9):1404-1410. PMC: 6407639. DOI: 10.1002/stem.2856. View

20.

Felice F, Piras A, Rocchiccioli S, Barsotti M, Santoni T, Pucci A . Endothelial progenitor cell secretome delivered by novel polymeric nanoparticles in ischemic hindlimb. Int J Pharm. 2018; 542(1-2):82-89. DOI: 10.1016/j.ijpharm.2018.03.015. View